TMO vs TOVX · P/E 24, rev $23.00B vs rev $300.0K
Thermo Fisher Scientific Inc (TMO) versus Theriva Biologics Inc. (TOVX) — a side-by-side from cached financials, not a winner call.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US. It is led by Marc N. Casper.
Theriva Biologics Inc. (TOVX) is a biotechnology company listed on NYSE MKT.
Latest reported TMO revenue for 2026-06-27 was $23.00B. Net income was $3.39B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Latest reported TOVX revenue for 2026-06-30 was $300.0K. Net income was -$5.3M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. TOVX currently screens at market cap $12.4M.
TMO currently screens at market cap $153.06B and trailing P/E 23.8. TOVX currently screens at market cap $12.4M.
Not investment advice. Open the TMO and TOVX stock pages for the full models.
Not investment advice.